These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16991209)

  • 1. VIP, PACAP, and related peptides: from gene to therapy. Proceedings of the 7th International Symposium on VIP, PACAP, and Related Peptides. September 11-14, 2005. Rouen, France.
    Ann N Y Acad Sci; 2006 Jul; 1070():1-628. PubMed ID: 16991209
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.
    Gonzalez-Rey E; Varela N; Chorny A; Delgado M
    Curr Pharm Des; 2007; 13(11):1113-39. PubMed ID: 17430175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.
    Cardoso JC; Vieira FA; Gomes AS; Power DM
    Peptides; 2007 Sep; 28(9):1902-19. PubMed ID: 17826180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization, expression, and functional activity of pituitary adenylate cyclase-activating polypeptide and its receptors in human granulosa-luteal cells.
    Morelli MB; Barberi M; Gambardella A; Borini A; Cecconi S; Coticchio G; Canipari R
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4924-32. PubMed ID: 18782879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the 3rd International Symposium on VIP, PACAP, and Related Peptides. Freiburg, Germany, September 17-20, 1997.
    Ann N Y Acad Sci; 1998 Dec; 865():1-611. PubMed ID: 10026089
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
    Baranowska-Bik A; Kochanowski J; Uchman D; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B; Bik W
    J Neuroimmunol; 2013 Oct; 263(1-2):159-61. PubMed ID: 24041830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory roles of VIP and PACAP in models of multiple sclerosis.
    Abad C; Waschek JA
    Curr Pharm Des; 2011; 17(10):1025-35. PubMed ID: 21524252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
    J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
    Maduna T; Lelievre V
    J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIP and PACAP.
    Fahrenkrug J
    Results Probl Cell Differ; 2010; 50():221-34. PubMed ID: 19859678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Ochiai T; Nawata H
    Endocrinology; 1998 Jun; 139(6):2869-78. PubMed ID: 9607796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 8th International Symposium on VIP, PACAP and Related Peptides. Symposium dedicated to the memory of Akira Arimura. September 3-8, 2007. Manchester, Vermont, USA.
    J Mol Neurosci; 2008 Nov; 36(1-3):1-339. PubMed ID: 19034707
    [No Abstract]   [Full Text] [Related]  

  • 16. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3rd International Symposium on VIP, PACAP, and Related Peptides. Freiburg, Germany, September 17-20, 1997. Abstracts.
    Regul Pept; 1997 Aug; 71(2):103-51. PubMed ID: 9446114
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of VIP and PACAP in islet function.
    Winzell MS; Ahrén B
    Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.